Cloning and characterization of the expression pattern of a novel splice product MIA (Splice) of malignant melanoma-derived growth-inhibiting activity (MIAY CD-RAP)

Journal of Investigative Dermatology

Volumn 119, Issue 3, 2002, Pages 562-569

  Hau, Peter ^a   Wise, Petra ^a   Bosserhoff, Anja Katrin ^a   Blesch, Armin ^b   Jachimczak, Piotr ^a   Tschertner, Ines ^a   Bogdahn, Ulrich ^a   Apfel, Rainer ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acid sensitive protein melanoma inhibiting; Activity melanoma; Alternative; Retinoic; Splicing cartilage derived

Indexed keywords

PROTEIN MIA; RECOMBINANT DNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL LINE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EXON; FRAMESHIFT MUTATION; GENE EXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INCUBATION TIME; MELANOMA; METASTASIS; MOLECULAR CLONING; MOLECULAR WEIGHT; PHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036381807     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.00501.x     Document Type: Article

References (30)

1. Abramovich C, Ratovitski E, Lundgren E, Revel M: Identification of mRNAs encoding two different soluble forms of the human interferon alpha-receptor. FEBS Lett 338(3):295-300, 1994.
2. Apfel R, Lottspeich F, Hoppe J, Behl C, Durr G, Bogdahn U: Purification and analysis of growth regulating proteins secreted by a human melanoma cell line. Melanoma Res 2(5-6):327-336, 1992.
3. Apfel R, Bosserhoff AK, Büttner R, Bogdahn U: Melanoma-Derived Growth Regulatory Protein (MIA/CD-RAP). In: Aggarwal BB (ed.). Human Cytokines. Handbook for Clinical Research III 149. 1998, pp 149-165.
4. Birnboim HC, Doly J: A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 7(6):1513-1523, 1979.
5. Bogdahn U, Apfel R, Hahn M, Gerlach M, Behl C, Hoppe J, Martin R: Autocrine tumor cell growth-inhibiting activities from human malignant melanoma. Cancer Res 49(19):5358-5363, 1989.
6. Bosserhoff AK, Kondo S, Moser M, et al: Mouse CD-RAP/MIA gene. structure, chromosomal localization, and expression in cartilage and chondrosarcoma. Dev Dyn 208(4):516-525, 1997.
7. Bosserhoff AK, Lederer M, Kaufmann M, et al:. MIA, a novel serum marker for progression of malignant melanoma. Anticancer Res 19(4A):2691-2693, 1999b.
8. Bosserhoff AK, Moser M, Hein R, Landthaler M, Buettner R:. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers. J Pathol 187(4):446-454, 1999a.
9. Breathnach R, Benoist C, O'Hare K, Gannon F, Chambon P: Ovalbumin gene. evidence for a leader sequence in mRNA and DNA sequences at the exon-intron boundaries. Proc Natl Acad Sci USA 75(10):4853-4857, 1978.
10. Brochez L, Naeyaert JM: Serological markers for melanoma. Br J Dermatol 143(2):256-268, 2000.
11. Butler MP, Wang SI, Chaganti RS, Parsons R, Dalla-Favera R: Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas. Genes Chromosomes Cancer 24(4):322-327, 1999.
12. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1):156-159, 1987.
13. Cohen-Salmon M, Frenz D, Liu W, Verpy E, Voegeling S, Petit C: Fdp, a new fibrocyte-derived protein related to MIA/CD-RAP, has an in vitro effect on the early differentiation of the inner ear mesenchyme. J Biol Chem 275(51):40036-40041, 2000.
14. Dietz UH, Sandell LJ: Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J Biol Chem 271(6):3311-3316, 1996.
15. Dreau D, Bosserhoff AK, White RL, Buettner R, Holder WD: Melanoma-inhibitory activity protein concentrations in blood of melanoma patients treated with immunotherapy. Oncol Res 11:55-61, 1999.
16. Hoffman JD, Hallam SE, Venne VL, Lyon E, Ward K: Implications of a novel cryptic splice site in the BRCA1 gene. Am J Med Genet 80(2):140-144, 1998.
17. Jachimzak P, Apfel R, Kempt P, et al: Immunosuppressive effects of melanoma-inhibiting activity (MIA). 2000, in press.
18. Jacoby LB, MacCollin M, Louis DN, et al: Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3(3):413-419, 1994.
19. Khyse-Anderson J.: Electroblotting of multiple gels. J Biochem Biophys Methods 10:203-205, 1984.
20. Koehler MR, Bosserhoff A, von Beust G, et al: Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-q13.33 by fluorescence in situ hybridization (FISH). Genomics 35:265-267, 1996.
21. Mutch MG, Dilley WG, Sanjurjo F, et al: Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects. Hum Mutat 13(3):175-185, 1999.
22. Pan et al: U.S. Patent WO 00/127622000, 2000.
23. Rendtorff ND, Frodin M, Attie-Bitach T, Vekemans M, Tommerup N: Identification and characterization of an inner ear-expressed human melanoma inhibitory activity (MIA)-like Gene (MIAL) with a frequent polymorphism that abolishes translation. Genomics 71:40-52, 2001.
24. Rinfret A, Anderson SK: IL-2 regulates the expression of the NK-TR gene via an alternate RNA splicing mechanism. Mol Immunol 30(14):1307-1313, 1993.
25. Robertson NG, Heller S, Lin JS, et al: A novel conserved cochlear gene, OTOR. identification, expression analysis, and chromosomal mapping. Genomics 66(3):242-248, 2000.
26. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: a Laboratory Manual, Vol. 1. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989.
27. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74(12):5463-5467, 1977.
28. Schägger H, von Jagow G: Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDalton. Anal Biochem 166:368-374, 1987.
29. Tavassoli K, Ruger W, Horst J: Alternative splicing in PAX2 generates a new reading frame and an extended conserved coding region at the carboxy terminus. Hum Genet 101(3):371-375, 1997.
30. de Vries TJ, Fourkour A, Punt CJ, Diepstra H, Ruiter DJ, van Muijen GN: Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells. low levels of MIA mRNA are present in various cell types and in peripheral blood. Br J Cancer 81(6):1066-1070, 1999.